Skip to main navigation

Contact Us
Global
- International
- Canada
- France
- Germany
- Italy
- Japan
- Netherlands
- Spain

About Amicus
- About Amicus
- Executive Chairman’s Welcome
- Belief Statement
- Our Founding Legacy
- Leadership
- Contact Us
- Message from the President and CEO
Patient Advocacy
- Patient Advocacy
- Rare Stories
- Patient Advisory Boards
- Resources
- Expanded Access
Programs & Pipeline
- Programs & Pipeline
- Our Pipeline
- Fabry Disease
- Pompe Disease
- Batten Disease
- Additional Preclinical Programs
- Clinical Trials
- Global Research Center
Products
- Products & Services
- Galafold^®(migalastat)
- Pombiliti^™ + Opfolda^™(cipaglucosidase alfa-atga) (miglustat)
- AMICUS ASSIST^®
Responsibility
- Responsibility
- Ethics & Compliance
- Global Medical Affairs
- Corporate Giving
- Healing Beyond Disease
- ESG Report
Investors & Media
- Investors & Media
- Investor Relations
- Senior Management Team
- Board of Directors
- Corporate Governance
- Press Releases
- Events & Presentations
- Annual Reports and Proxies
- SEC Filings
- Stock Performance
- Investor FAQs
- Contact Us
- Sign Up for Email Alerts
Careers
- Careers
- Overview
- Search

Investors

Press Releases

Press Releases

Year

February 27, 2023

Amicus Therapeutics to Present at the Cowen 43rd Annual Health Care Conference

February 22, 2023

Amicus Therapeutics Announces Positive Long-Term Data from Phase 3 Open-label Extension Study of AT-GAA in Late-Onset Pompe Disease at the 19th Annual WORLDSymposium™ 2023

February 14, 2023

Amicus Therapeutics to Announce Full-Year 2022 Financial Results on March 1, 2023

February 13, 2023

Amicus Therapeutics Announces Presentations and Posters at the 19th Annual WORLDSymposium™ 2023

February 8, 2023

Amicus Therapeutics to Present at the SVB Securities Global Biopharma Conference

January 9, 2023

Amicus Therapeutics Reports Preliminary 2022 Revenue and Provides 2023 Strategic Outlook

January 3, 2023

Amicus Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

Pagination

First page
Previous page
Page 1
Page 2
Current page 3

About Amicus

Patient Advocacy

Programs & Pipeline

Our Products
- Overview
- Amicus Assist™

Responsibility

Investors & Media

Careers
- Overview
- Search

Social Media
- Twitter
- YouTube
- LinkedIn

Copyright © 2023 Amicus Therapeutics. All rights reserved. NP-AT-ALL-00011119

Cookies Statement
Terms of Use
Privacy Notice
Privacy Shield Policy

The site you are about to enter is intended for US healthcare professionals.

Please confirm you are a US healthcare professional.

I am a US healthcare professional I am not a US healthcare professional